Gene Nudelman: Can a Hemostatic Gauze Perform When Blood Clotting is Impaired?
Gene Nudelman, CEO at Core Scientific Creations Ltd, shared a post on LinkedIn:
“Can a hemostatic gauze perform when blood clotting is impaired?
Independent testing conducted at the University Hospital of Tübingen evaluated Wound Clot Advanced Bleeding Control in fresh human blood containing increasing concentrations of heparin.
The results demonstrated clot formation an000d coagulation activation in blood containing up to 3–4 IU/mL heparin, highlighting Wound Clot’s ability to support hemostasis under challenging anticoagulated conditions.
For trauma teams, surgeons, military medics, and emergency responders, every second matters – and so does confidence in the technology being used.
When clotting is compromised, performance matters.”
Stay updated with Hemostasis Today.
-
Nov 7, 2026, 16:15Mazyar Shadman: Novel BTK Inhibitors and DOACs A Multicenter Study of Bleeding Risk
-
Nov 7, 2026, 15:54Hassan Raza: Beyond the 100 Minus Age Rule in Bone Marrow Cellularity
-
Nov 7, 2026, 15:42Andrew Zapfel։ Advancing Sickle Cell Disease Care Through Training, Advocacy and Collaboration
-
Nov 7, 2026, 15:34Salih Ehsan: Iron Deficiency Beyond Conventional Ferritin Cutoffs
-
Nov 7, 2026, 15:21Shamee Shastry: Improving the Reliability and Reproducibility of the Monocyte Monolayer Assay
-
Nov 7, 2026, 14:39AI-Assisted Donor Screening and Transfusion Decision Support: A Prospective Multicentre Evaluation
-
Nov 7, 2026, 14:26Qiong Tang: Changing Perspectives on Iron Deficiency and Supplementation
-
Nov 7, 2026, 14:21Nathan Connell: Bringing VWD Education Across Borders to Improve Patient Care
-
Nov 7, 2026, 14:02David McIntosh: Thalassaemia Care Needs More Than Breakthrough Therapies